The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

More than half of Americans take daily multivitamins and dietary supplements, but doctors and pharmacists say many of them ...

Medically reviewed by Jonathan Purtell, RDNVitamin C (ascorbic acid) is a water-soluble vitamin that cannot be stored in the ...